BrunoSan Finance Intelligence · April 30, 2026
Finance Intelligence News
Every article includes an Intel Score breakdown — so you know exactly how strong each signal is and where it came from. Not editorial judgment. Signal mathematics.
🏦 RATE DECISION
1.000
ECB and BoE Hold Rates, Cornered by Rising Fuel Prices and Stagflationary Threat
The European Central Bank and Bank of England held key policy rates at 3.00% and 4.25% respectively, signaling that persistent inflation from rising fuel prices is forcing a hawkish pause despite mounting recessionary risks, reflected in the German 10Y-2Y spread inverting to -15 basis points.
📊 EARNINGS
1.000
Amazon Q1 Earnings: AWS Re-acceleration to 28% Growth Signals Renewed Enterprise Spend
Amazon reported Q1 2026 EPS of $1.15, beating consensus by 9.5%, driven by a significant re-acceleration in AWS revenue growth to 28% year-over-year, signaling a robust recovery in enterprise cloud demand.
📊 EARNINGS
1.000
HSBC and NAB Earnings Outlooks Diverge on Middle East Geopolitical Risk
Upcoming earnings from HSBC and National Australia Bank face direct headwinds from Middle East geopolitical risk, with analysts flagging potential for increased loan-loss provisions, a stark contrast to the more insulated outlook for Singapore's top 3 banks.
🏦 RATE DECISION
1.000
Fed Holds Rates at 5.50%, Hawkish Pause Creates Headwind for Gold Buyers
The Federal Reserve held the federal funds rate at 5.25%-5.50% on April 29, 2026, signaling persistent inflation risks that challenge the case for gold's continued rally despite recent dip-buying activity.
🚀 IPO
1.000
Novo-Backed Avalyn Pharma Prices Upsized IPO at $19, Raising $300M for Lung Disease Pipeline
Avalyn Pharma (AVLY) raised $300 million in an upsized IPO, pricing 15.8 million shares at $19, the top of its range, signaling robust institutional demand for specialized biopharma assets backed by strategic capital like Novo Holdings and establishing a new valuation benchmark for the sector.